Showing results (1-10 of 668) with videos related to

Sort By:
Pageof 67
Circulation|March 27, 2002
Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factorsFrank M Sacks, Andrew M Tonkin, Timothy Craven, et al.
Heart Failure Reviews|April 11, 2008
Anemia treatment in chronic kidney disease: shifting uncertaintyMarc A Pfeffer
The American Heart Hospital Journal|November 13, 2004
Pharmacologic advances in long-term heart failure managementMarc A Pfeffer
The Medical Clinics of North America|November 26, 2016
Heart Failure and Hypertension: Importance of PreventionMarc A Pfeffer
The American Journal of Cardiology|December 17, 2008
After the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: implications for fenofibrateFrank M Sacks
Current Opinion in Lipidology|January 1, 2015
The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemiaFrank M Sacks
Atherosclerosis. Supplements|July 11, 2006
The apolipoprotein storyFrank M Sacks
The Journal of Clinical Psychiatry|December 17, 2004
Metabolic syndrome: epidemiology and consequencesFrank M Sacks
Circulation|May 22, 2002
Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) ProjectMarc A Pfeffer, Anthony Keech, Frank M Sacks, et al.
Annual Review of Medicine|November 4, 2006
Kidney disease and cardiovascular riskMarcello Tonelli, Marc A Pfeffer
Pageof 67